Home/Vera Therapeutics/Robert M. Brenner, MD
RM

Robert M. Brenner, MD

Chief Medical Officer

Vera Therapeutics

Vera Therapeutics Pipeline

DrugIndicationPhase
AtaciceptIgA Nephropathy (IgAN)Phase 2b/3
MAU868BK Virus Viremia in Kidney Transplant PatientsPhase 2